ISOBM 2015 - Oncology in the Biomarker Era: Biology – Diagnostics – Therapy

 

www.isobm-congress.pl

 

The 42^nd Congress of the International Society of Oncology and Biomarkers will be held in Zakopane, Poland, 3-7 October 2015. ISOBM organises the congress in collaboration with the European Group on Tumor Markers, with support of Polish Oncological Society and Polonorum Societas Biologiae Cellulae and several other Polish and international societes.

 

The International Society of Oncology and Biomarkers (ISOBM), founded in the early 1970s, welcomes all interested in cancer biomarkers, tumour biology and novel cancer therapies.

 

The theme of the 42th Congress, ‘Oncology in the Biomarker Era: Biology – Diagnostics – Therapy’, will cover most important fields of cancer research and oncology, including numerous aspects of personalised management of cancer patients, and will provide a platform for scientists, doctors and laboratory medicine specialists to share their knowledge, experience and different points of view.

 

The participants will have an opportunity to exchange ideas and expertise in an international forum, to engage in collaboration, to meet with colleagues from all over the world, and to attend lectures delivered by prominent leaders in the field of Cancer Research, Oncology and Biomarkers.

 

KEYNOTE LECTURES will be given by:

prof. Aaron Ciechanover, 2004 Nobel Prize winner

prof. Herbert Fritsche, world expert on tumour markers

prof. Phil Gold, carcinoembionic antigen discoverer

prof. Ulf-Håkan Stenman, known for his outstanding contributions to standardisation of diagnostic assays

 

The scientific programme will also include:

20 ORAL SESSIONS

2 ROUND TABLE DISCUSSIONS

POSTER SESSIONS throughout the congress

 

Topics:

1. Classical Tumour Markers Present and Future I

2. From Tumour Biology to Biomarker-Based Decisions

3. European Group for Tumour Markers Session

4. Big Data for Biomarker Development

5. Circulating Cancer Cells

6. Molecular Therapeutics and Predictive Biomarkers

7. Immunotherapy and Immunological Markers for the Management of Cancer Patients

8. Biobanking/Horizon 2020

9. Interdisciplinary Challenges

10. Hormones in the Aetiopathogenesis of Cancer

11. Liquid Biopsy

12. Molecularly-Driven Therapies

13. Cancer Stem Cells

14. Cancer Risk and Cancer Screening

15. Epigenetic Profiling, Tumour-Derived Nucleic Acids 

16. Towards Molecular Oncology - IncoNet EaP Session

17. Anticancer Drugs - New Developments, New Strategies

18. Molecular Tracing of Metastatic/Residual Diseases

19. Classical Tumour Markers Present and Future II

20. Targeting Tumour Microenvironment

 

Accepted abstracts will be published in Tumor Biology IF=3,611), the official ISOBM journal.

 

ISOBM 2015 has applied for accreditation with the UEMS-EACCME®

Laboratory diagnosticians participating in the ISOBM 2015 Congress will earn 31 credits from the National Chamber of Laboratory Medicine.

 

Zakopane, the Congress site, is a beautiful and well-known Polish Tatra mountain resort, renowned for its unique architectural style and for the hospitality of the locals. It is located 100 km south from Kraków (Cracow), the capital of Poland until the XVIth century, known for a magnificent Royal Castle and one of the oldest universities in Europe.

 

To view the agenda, full list of speakers, and other details please visit www.isobm-congress.pl

Congress Office: bozena.chowaniec@trip.pl